Lal PathLabs targets leadership position in west India in 5 years

Om Manchanda, MD, Dr Lal Pathlabs said that the contribution of the west zone has gone up from 6 percent in FY15 to 8 percent in FY20 and 15 percent in the first half of FY23

India’s largest private diagnostic player Dr Lal PathLabs is now eyeing a leadership position in the western India market within the next five years. It plans to do so on the back of Suburban Diagnostics, its wholly-owned subsidiary. 

Suburban Diagnostics, which draws almost 70-80 per cent of its revenue from the Mumbai market, has now opened a 13,000 square feet reference laboratory in the city. This is the first Biosafety level-3 (BSL-3) laboratory by any private diagnostic player, the company said. 

Om Manchanda, MD, Dr Lal PathLabs said that the contribution of the west zone has increased from 6 per